ACCUSIGN DOA 8, ACCUSIGN DOA 8 PANEL, ACCUSIGN THC/OPI/COC/AMP/BZO/BAR/TCA/PCP, BIOSIGN DOA 8, BIOSIGN THC/OPI/COC/AMP/P— 510(k) K983147
Substantially EquivalentPrinceton BioMeditech Corp.
FDA 510(k) clearance K983147 for ACCUSIGN DOA 8, ACCUSIGN DOA 8 PANEL, ACCUSIGN THC/OPI/COC/AMP/BZO/BAR/TCA/PCP, BIOSIGN DOA 8, BIOSIGN THC/OPI/COC/AMP/P, Substantially Equivalent on 1998-09-28. Applicant: Princeton BioMeditech Corp..
Clearance details
- Applicant
- Princeton BioMeditech Corp.
- Product code
- Code DKE
- Advisory panel
- Clinical Toxicology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Princeton, NJ, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.